Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability.
about
Cannabinoids for pediatric epilepsy? Up in smoke or real science?TRPV1 Channel: A Potential Drug Target for Treating EpilepsyCannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the EvidenceThe pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.The Pharmacological Basis of Cannabis Therapy for Epilepsy.Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders.Interference of TRPV1 function altered the susceptibility of PTZ-induced seizuresMolecular Targets of Cannabidiol in Neurological DisordersWittig derivatization of sesquiterpenoid polygodial leads to cytostatic agents with activity against drug resistant cancer cells and capable of pyrrolylation of primary aminesAnalysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndromeNeural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.Molecular Targets of the Phytocannabinoids: A Complex Picture.Phytocannabinoids and epilepsy.Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.Are big potassium-type Ca(2+)-activated potassium channels a viable target for the treatment of epilepsy?Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function.The Endocannabinoid System and its Modulation by Phytocannabinoids.The potential role of cannabinoids in epilepsy treatment.Quantitative Analyses of Synergistic Responses between Cannabidiol and DNA-Damaging Agents on the Proliferation and Viability of Glioblastoma and Neural Progenitor Cells in Culture.Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series.Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists.Molecular Pharmacology of Phytocannabinoids.Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment.Nociceptor plasticity: A closer look.Modulation of Human Neutrophil Responses by the Essential Oils from Ferula akitschkensis and Their Constituents.Cannabidiol Modulates the Expression of Alzheimer's Disease-Related Genes in Mesenchymal Stem Cells.Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis.Duloxetine Reduces Oxidative Stress, Apoptosis, and Ca2+ Entry Through Modulation of TRPM2 and TRPV1 Channels in the Hippocampus and Dorsal Root Ganglion of Rats.Modulation of Diabetes-Induced Oxidative Stress, Apoptosis, and Ca2+ Entry Through TRPM2 and TRPV1 Channels in Dorsal Root Ganglion and Hippocampus of Diabetic Rats by Melatonin and Selenium.Do Cannabinoids Confer Neuroprotection Against Epilepsy? An Overview.Evaluation of Cannabidiol in Animal Seizure Models by the Epilepsy Therapy Screening Program (ETSP).Short-Term Ketamine Treatment Decreases Oxidative Stress Without Influencing TRPM2 and TRPV1 Channel Gating in the Hippocampus and Dorsal Root Ganglion of Rats.Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.Cannabinoids for epilepsy: What do we know and where do we go?CGRP and Visceral Pain: The Role of Sex Hormones in In Vitro Experiment.Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells.Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation.Cannabidiol exerts antiepileptic effects by restoring hippocampal interneuron functions in a temporal lobe epilepsy model.Cannabis in epilepsy: From clinical practice to basic research focusing on the possible role of cannabidivarin.
P2860
Q26770299-178F0EC4-37D1-47D5-A6EC-FD424523C8EBQ26786478-FAD5ED3E-4E8E-46E3-B358-ED4EA2609AE9Q28075499-D250BC7B-C438-4C8D-85B0-7964F052CC3AQ31122398-BB81EE8D-00BB-4920-99CF-55609FDAD0B1Q34509920-65F820C6-9D61-41C8-ADC2-B476E99EFC05Q34557613-AC8DFBF1-5459-4EAE-ABD5-7A81586ECBD3Q35067058-A003D338-2B79-43A3-8C56-D5E21E722CABQ36157649-4A77BCB4-542C-4905-95DC-08F1565448A3Q36198988-C4D918B1-B6AF-4259-BF03-50A28817CB10Q36719661-548BF33F-7D4A-4801-9FD6-DA919F2B8A2EQ36744227-8BB9A53D-EE7E-4E71-BA41-F5DB04C1342DQ37692746-2F468C4B-7B94-4E9E-833B-039BE6094ED0Q38283251-A4826039-5C07-4B88-99EB-687C6C677FF9Q38299472-0DF58466-D6A3-471A-81AD-340A574F88F1Q38404580-EAF7FE17-48FB-4F5A-806F-4275AB84DB68Q38520997-ED0C882E-9A1D-476A-AC3D-CBAFC36C8FD9Q38566339-FE801EA3-3222-461F-AC30-C79B76CC8A52Q38606080-C05C3699-199C-435F-83CC-535CB875408CQ38732473-6A5C95BD-D3C1-425D-AD18-CB7547CDE50AQ38791924-A216C483-C390-4761-B8C4-303C346DBE5FQ39038882-AD2019AB-67EA-4B87-A18A-A1E7F5AF5599Q39102188-8D0D7352-A524-4C85-86A0-6939F3C0A370Q39152497-530AD220-4E8B-48D3-A4F3-C5D534B3A70EQ39295296-107B47AD-C650-4D9C-9405-0935936CF29FQ41674502-C3931D67-DEA5-415D-B419-08A271C39A82Q42323226-821DA727-926D-49BD-86F3-86DEFC9F95A8Q42689224-CFFB5CBA-45A5-4F6C-A7E4-5E07BF1D5C4CQ46513233-CBE92444-2DC3-4894-8201-0148C6B1CA93Q46582896-510349DF-EA3E-4DE3-B750-2DA1A843054CQ47125735-84F7FAA1-137D-41F3-BC29-43C00940406CQ47378591-306814D9-5C6D-43E8-BB08-DC081450603DQ47583670-CFD06D4B-CC97-4680-9369-10E0D617DE02Q47643955-6AA515C1-E39F-41A8-8579-95D92A805D0DQ47958585-C5F3E84E-5C43-4479-B27B-B46E9936B500Q48162585-1F1B5573-5B91-4FA4-9123-1176CBC222D7Q51178352-AD969E31-D442-4583-9878-8CF608212F4EQ51285452-D000BFC8-1B97-405A-870B-64D4EEE9453BQ51316104-5AA5F692-9640-4D95-B95E-ED79852BD4E3Q51735358-86DCF421-6AF3-411C-B5A3-F486E9CB3308Q53572433-43B650F8-93FF-40F4-B815-D2B0D6E0378D
P2860
Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Nonpsychotropic plant cannabin ...... of neuronal hyperexcitability.
@en
Nonpsychotropic plant cannabin ...... of neuronal hyperexcitability.
@nl
type
label
Nonpsychotropic plant cannabin ...... of neuronal hyperexcitability.
@en
Nonpsychotropic plant cannabin ...... of neuronal hyperexcitability.
@nl
prefLabel
Nonpsychotropic plant cannabin ...... of neuronal hyperexcitability.
@en
Nonpsychotropic plant cannabin ...... of neuronal hyperexcitability.
@nl
P2093
P50
P921
P356
P1476
Nonpsychotropic plant cannabin ...... of neuronal hyperexcitability.
@en
P2093
Ahlam Alhusaini
Benjamin J Whalley
Camille Soubrane
Charlotte L Hill
Enrico Mazzarella
Gary J Stephens
P304
P356
10.1021/CN5000524
P577
2014-07-29T00:00:00Z